JENNIFER CARTER: Open Payments
NPI 1346844917 · WESTWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,183 in 42 payments from 11 companies in 2025. Trend: 2023 $825 · 2024 $7,038 · 2025 $10,183
Speaker / faculty: $8,000Food & beverage: $1,598Travel & lodging: $487Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $9,240 |
| Stemline Therapeutics Inc. | 4 | $321 |
| Gilead Sciences, Inc. | 9 | $228 |
| Daiichi Sankyo Inc. | 3 | $114 |
| SEAGEN INC. | 1 | $99 |
| Caris MPI, Inc. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Lilly USA, LLC | 1 | $22 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $22 |
| Incyte Corporation | 1 | $20 |
Products named: Orserdu, Trodelvy, Enhertu, DATROWAY, MI CANCER SEEK, KISQALI, VERZENIO, NERLYNX.
Industry payments across KS — which companies pay providers there.
